Table 1.
CTL n=6 |
CSN8hypo n=8 |
CTL::CryABR120G n=10 |
CSN8hypo::CryABR120G n=8 |
|
---|---|---|---|---|
Body weight (g) | 30.4±2.1 | 27.2±3.5 | 28.2±3.7 | 28.8±4.2 |
Heart rate (bpm) | 471±24 | 487±42 | 432±43 | 472±43 |
LVIDd (mm) | 4.37±0.35 | 4.09±0.14 | 3.90±0.26† | 3.54±0.28†‡ |
LVPWd (mm) | 0.70±0.13 | 0.73±0.13 | 0.93±0.15† | 0.88±0.06* |
LVIDs (mm) | 3.17±0.26 | 3.12±0.21 | 2.45±0.22† | 1.89±0.22†‡ |
LVPWs (mm) | 1.13±0.12 | 1.09±0.24 | 1.45±0.27† | 1.44±0.14† |
LVAWd (mm) | 0.71±0.08 | 0.67±0.12 | 1.00±0.20† | 0.97±0.19† |
LVAWs (mm) | 1.15±0.12 | 1.03±0.27 | 1.52±0.25† | 1.55±0.21† |
LV FS (%) | 30.02±2.48 | 28.59±2.00 | 37.84±5.93* | 45.07±4.11†‡ |
LV EF (%) | 53.83±5.68 | 58.55±5.52 | 65.19±8.95* | 77.25±4.20†‡ |
LVVd (mm3) | 87.58±15.20 | 77.33±2.40 | 66.20±10.92† | 49.59±11.02†‡ |
LVVs (mm3) | 40.28±8.18 | 41.29±6.18 | 22.28±9.46† | 11.31±3.41†‡ |
SV (µl) | 47.3±10.3 | 35.2±6.2 | 43.9±6.7 | 38.3±8.6 |
CO (ml/min) | 22.3±4.9 | 17.2±3.9 | 19.0±4.3 | 18.1±4.2 |
LVIDd, end-diastolic left ventricular (LV) internal diameter; LVIDs, end-systolic LVID; LVPWd, end-diastolic LV posterior wall thickness; LVPWs, end-systolic LVPW; LVAWd, end-diastolic LV anterior wall thickness; LVAWs, end-systolic LVAW; FS, fractional shortening; EF, ejection fraction; LVVd, end-diastolic LV volume; LVVs, end-systolic LVV; SV, stroke volume; CO, cardiac output.
p<0.05,
p<0.01 vs. CTL;
p<0.05 vs. CTL::CryABR120G; ANOVA followed by the Scheffé test.